Recent Healthcare Financings
| Company Name | Amount Raised | Type of Fundraise | Country | Date |
| Private Company Financings | ||||
| OTR Therapeutics | $100 million | Series A | China | 4 December |
| SciNeuro Pharmaceuticals | $53 million | N/A | US | 4 December |
| SanegeneBio | $110 million | Series B | US | 8 December |
| D3 Bio | $108 million | Series B | China | 8 December |
| BlossomHill Therapeutics | $84 million | Series B extension | US | 10 December |
| PsiThera | $47.5 million | Series A | US | 10 December |
| Prolynx | $70 million | Series A | US | 11 December |
| Link Cell Therapies | $60 million | Series A | US | 15 December |
| Chai Discovery | $130 million | Series B | US | 15 December |
| Ambros Therapeutics | $125 million | Series A | US | 16 December |
| Aeovian Pharmaceuticals | $55 million | Series B | US | 16 December |
| Addition Therapeutics | $100 million | N/A | US | 17 December |
| Atavistik Bio | $120 million | Series B | US | 18 December |
| Syremis Therapeutics | $165 million | Series A | Israel/US | 18 December |
| Syneron Bio | ~ $100 million | Series A extension | China | 18 December |
| Public Company Financings | ||||
| Crescent Biopharma | $185 million | Private Placement | US | 4 December |
| Immatics | $125 million | Public Offering | Germany/US | 5 December |
| Capricor Therapeutics | $150 million | Public Offering | US | 5 December |
| Immix Biopharma | $ 100 million | Public offering | US | 7 December |
| Dyne Therapeutics | $402.5 million | Public Offering | US | 11 December |
| Immunovant | $550 million | N/A | US | 11 December |
| Kymera Therapeutics | $602 million | Public Offering | US | 11 December |
| Jade Biosciences | $45 million | Private Placement | US | 15 December |
| Vor Bio | $150 million | Private Placement | US | 15 December |